Trials / Completed
CompletedNCT02858544
Concussion in Motor Vehicle Accidents: The Concussion Identification Index
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,790 (actual)
- Sponsor
- Clionsky Neuro Systems Inc. · Industry
- Sex
- All
- Age
- 10 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of this study is to provide clinicians with a brief, patient self-administer instrument yielding a single composite score that reliably correlates with objective findings on standardized neurocognitive assessment for concussion.
Detailed description
This Phase 2 study, Concussion in Motor Vehicle Accidents - The Concussion Identification Index (CIDI), focuses on the psychometric properties of the relationship between acute injury events, i.e. head impact, loss of consciousness (LOC), and post-traumatic amnesia (PTA), commonly reported post-crash signs and symptoms, and neurocognitive outcomes. Cohort 1 is the validation group and will be used to confirm the optimal cut-off score of the Concussion Identification Index (CIDI) with the score on the ImPACT. Cohort 2 is the cross-validation group.
Conditions
- Motor Vehicle Accidents
- TBI (Traumatic Brain Injury)
- Brain Contusion
- Brain Injuries
- Cortical Contusion
- Concussion Mild
- Cerebral Concussion
- Brain Concussion
- Accidents, Traffic
- Traffic Accidents
- Traumatic Brain Injury With Brief Loss of Consciousness
- Traumatic Brain Injury With no Loss of Consciousness
- Traumatic Brain Injury With Loss of Consciousness
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | The Concussion Identification Index | Patient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms |
| OTHER | ImPACT | Patient- completed computerized neurocognitive test battery |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-08-08
- Last updated
- 2016-08-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02858544. Inclusion in this directory is not an endorsement.